Faculty, Staff and Student Publications

Publication Date

12-5-2024

Journal

Nature Communications

Abstract

Recurrent ovarian cancer patients, especially those resistant to platinum, lack effective curative treatments. To address this, we conducted a phase 2 clinical trial (NCT02853318) combining pembrolizumab with bevacizumab, to increase T cell infiltration into the tumor, and oral cyclophosphamide, to reduce the number of regulatory T cells. The trial accrued 40 heavily pretreated recurrent ovarian cancer patients. The primary endpoint, progression free survival, was extended to a median of 10.2 months. The secondary endpoints demonstrated an objective response rate of 47.5%, and disease control in 30% of patients for over a year while maintaining a good quality of life. We performed comprehensive molecular, immune, microbiome, and metabolic profiling on samples of trial patients. Here, we show increased T and B cell clusters and distinct microbial patterns with amino acid and lipid metabolism are linked to exceptional clinical responses. This study suggests the immune milieu and host-microbiome can be leveraged to improve antitumor response in future immunotherapy trials.

Keywords

Humans, Female, Ovarian Neoplasms, Immunotherapy, Gastrointestinal Microbiome, Bevacizumab, Middle Aged, Antibodies, Monoclonal, Humanized, Aged, Cyclophosphamide, Progression-Free Survival, Adult, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Recurrence, Local, Quality of Life, Treatment Outcome, Multiomics

DOI

10.1038/s41467-024-54565-8

PMID

39638782

PMCID

PMC11621351

PubMedCentral® Posted Date

12-5-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.